MedTrace Logo

Depression, Anxiety and SARS-CoV-2 (Covid-19) Phobia in Post-stroke Patients

NCT04560413 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2020-09-30

No results posted yet for this study

Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has begun, first in Wuhan, China, and then became a pandemic. The first SARS-CoV-2 case in Turkey was reported on March 11, 2020. People older than 65 years old became subject to lock down measures beginning on March 21, while people younger than 20 years old became subject to lock down measures beginning on April 03. A total lock down has been implemented a few times lasting between 3 to 4 days, especially at weekends. Several studies show that mental health problems could occur in public during the SARS-CoV-2 pandemic.

Depression and anxiety are a commonly known mental health issue in post-stroke patients. This patient population, who usually have to spend most of their time at home, remained completely at home and socially isolated due to the precautions required by the pandemic. Based on the above research evidence; depression, anxiety and phobia of SARS-CoV-2 may increase in the post stroke patients due to being in risk group and effects of measures taken against SARS-CoV-2 pandemic. Therefore, we aimed to assess the depression, anxiety and SARS-CoV-2 phobia in post stroke patients during SARS-CoV-2 outbreak, and to explore the potential influence factors.

Conditions

  • SARS-CoV-2
  • Post-stroke Depression
  • Anxiety and Fear

Sponsors & Collaborators

  • Fatih Sultan Mehmet Training and Research Hospital

    lead OTHER

Principal Investigators

  • Duygu Silte Karamanlioglu, MD · Fatih Sultan Mehmet Training and Research Hospital

  • Arzu Atici, MD · Fatih Sultan Mehmet Training and Research Hospital

  • Gulcan Ozturk, MD · Fatih Sultan Mehmet Training and Research Hospital

  • Pinar Akpinar, Assoc Prof · Fatih Sultan Mehmet Training and Research Hospital

  • Feyza Unlu Ozkan, Assoc Prof · Fatih Sultan Mehmet Training and Research Hospital

  • Ilknur Aktas, Prof · Fatih Sultan Mehmet Training and Research Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2020-07-25
Completion
2020-08-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04560413 on ClinicalTrials.gov